TSS
ACAD icon

Two Sigma Securities’s Acadia Pharmaceuticals ACAD Stock Holding History

Two Sigma Securities’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,269
Closed -$311K – 1287
2019
Q4 		$311K Sell
7,269
-2,716
-27% -$118K 0.02% 1762
2019
Q3 		$359K Buy
+9,985
New +$303K 0.04% 1418
2019
Q2 		– Hold
0
– – – 2044
2019
Q1 		– Hold
0
– – – 1769
2017
Q4 		– Sell
-5,867
Closed -$221K – 1705
2017
Q3 		$221K Sell
5,867
-4,997
-46% -$163K 0.02% 540
2017
Q2 		$303K Buy
+10,864
New +$324K 0.06% 358

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return